These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 23239818)
1. Immune response evaluation through determination of type 1, type 2, and type 17 patterns in patients with epithelial ovarian cancer. Cândido EB; Silva LM; Carvalho AT; Lamaita RM; Filho RM; Cota BD; da Silva-Filho AL Reprod Sci; 2013 Jul; 20(7):828-37. PubMed ID: 23239818 [TBL] [Abstract][Full Text] [Related]
2. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer. Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936 [TBL] [Abstract][Full Text] [Related]
3. Th1/Th2 CD4+ T cell responses against NY-ESO-1 in HLA-DPB1*0401/0402 patients with epithelial ovarian cancer. Qian F; Gnjatic S; Jäger E; Santiago D; Jungbluth A; Grande C; Schneider S; Keitz B; Driscoll D; Ritter G; Lele S; Sood A; Old LJ; Odunsi K Cancer Immun; 2004 Nov; 4():12. PubMed ID: 15521719 [TBL] [Abstract][Full Text] [Related]
4. Elevated Th22 cells and related cytokines in patients with epithelial ovarian cancer. Wang T; Zhang Z; Xing H; Wang L; Zhang G; Yu N; Wang J; Guo W; Jiang J Medicine (Baltimore); 2017 Oct; 96(43):e8359. PubMed ID: 29069020 [TBL] [Abstract][Full Text] [Related]
5. Sub-optimal primary surgery leads to unfavorable immunological changes in ovarian cancer patients. Nowak M; Głowacka E; Lewkowicz P; Banasik M; Szyłło K; Zimna K; Bednarska K; Klink M Immunobiology; 2018 Jan; 223(1):1-7. PubMed ID: 29017822 [TBL] [Abstract][Full Text] [Related]
14. Biomarker potential of IL-6 and VEGF-A in ascitic fluid of epithelial ovarian cancer patients. Dalal V; Kumar R; Kumar S; Sharma A; Kumar L; Sharma JB; Roy KK; Singh N; Vanamail P Clin Chim Acta; 2018 Jul; 482():27-32. PubMed ID: 29572186 [TBL] [Abstract][Full Text] [Related]
15. Natural Killer Cells Response to IL-2 Stimulation Is Distinct between Ascites with the Presence or Absence of Malignant Cells in Ovarian Cancer Patients. da Silva RF; Yoshida A; Cardozo DM; Jales RM; Paust S; Derchain S; Guimarães F Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28513532 [TBL] [Abstract][Full Text] [Related]
16. Changes in the Ratio of T Helper 1 to T Helper 2 Signature Cytokines in Patients Undergoing Living Donor Liver Transplantation Surgery: A Prospective Controlled Study. Lee HM; Ghill BK; Park E; Park CY; Choi WK; Lee J Transplant Proc; 2018 Dec; 50(10):3621-3625. PubMed ID: 30577247 [TBL] [Abstract][Full Text] [Related]
17. [Changes of Th1/Th2/Th17 in patients received non-myeloablative haploidentical hematopoietic stem cell transplantation detected by flow cytometric bead array]. Zhao YY; Kang Y; Sun QY; Dong Z; Liu TQ; Liu GX; Guo M; Ai HS Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):431-5. PubMed ID: 23628048 [TBL] [Abstract][Full Text] [Related]
18. Interaction between Treg cells and tumor-associated macrophages in the tumor microenvironment of epithelial ovarian cancer. Zhu Q; Wu X; Wu Y; Wang X Oncol Rep; 2016 Dec; 36(6):3472-3478. PubMed ID: 27748885 [TBL] [Abstract][Full Text] [Related]
19. TNF-α inhibitors reduce the pathological Th Campanati A; Orciani M; Lazzarini R; Ganzetti G; Consales V; Sorgentoni G; Di Primio R; Offidani A Exp Dermatol; 2017 Apr; 26(4):319-324. PubMed ID: 27376466 [TBL] [Abstract][Full Text] [Related]
20. The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications. Waśkiel-Burnat A; Osińska M; Salińska A; Blicharz L; Goldust M; Olszewska M; Rudnicka L Cells; 2021 Dec; 10(12):. PubMed ID: 34943905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]